Brad Brekke

Brad Brekke, JD has a wealth of experience in the pharmaceutical industry. Brad is currently the Director of Market Access at argenx since September 2022. Prior to this, they served as the National Account Director at Ascendis Pharma from April 2021 to November 2022. Brad was also the National Account Director at Rhythm Pharmaceuticals Inc. from September 2020 to July 2022. From July 2019 to September 2020, Brad worked as the National Account Director, Payer at Coherus BioSciences and also as National Account Director, Rare Blood Disorders Franchise at Sanofi Genzyme from February 2019 to September 2020. Before that, they worked at Bioverativ, a Sanofi company, as a National Account Manager from January 2017 to July 2019, where they successfully drove sales growth and managed customer relationships. Prior to Bioverativ, Brad held various roles at Hospira, Biogen, Amgen, and Reckitt Benckiser Pharmaceuticals.

Brad Brekke, JD attended the University of Wisconsin-Madison from 1987 to 1991, where they obtained a Bachelor of Arts (B.A.) degree. Brad then went on to study at the University of Wisconsin Law School from 1992 to 1995, earning a JD degree in Law.